Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

CDC Media Relations
Media Home | Contact Us
US Department of Health and Human Services logo and link

Media Relations Links
• About Us
• Media Contact
• Frequently Asked Questions
• Media Site Map

CDC News
• Press Release Library
• Transcripts
• MMWR Summaries
• B-Roll Footage
• Upcoming Events

Related Links
• Centers at CDC
• Data and Statistics
• Health Topics A-Z
• Image Library
• Publications, Software and Other Products
• Global Health Odyssey
Find your state or local health department
HHS News
National Health Observances
Visit the FirstGov Web Site
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394


MMWR
Synopsis for March 22, 2002

The MMWR is embargoed until NOON, ET.

  1. Tuberculosis Outbreak on an American Indian Reservation — Montana, 2000–2001
  2. Progress Toward Tuberculosis Control — India, 2001
  3. Progress Towards Elimination of Haemophilus influenzae Type b Invasive Disease Among Infants and Children — United States, 1998–2000

Notice to Readers

Satellite Broadcast on HIV Prevention
Contact: Office of Communications
CDC, National Center for HIV, STD and TB Prevention
(404) 639–8895

MMWR Surveillance Summaries
March 22, 2002

Asthma Surveillance - United States, 1980-1998 and Malaria Surveillance-United States, 1999

Contacts: "Asthma Report"
David Mannino, M.D.
CDC, National Center for Environmental Health
(404) 498-1014

"Malaria Report"
Robert Newman, M.D.
CDC, National Center for Infectious Diseases
(770) 488-7559



Telebriefing, March 21, 2002
WHO: Ken Castro, M.D. and Lorna Thorpe, Ph.D., CDC TB experts
WHAT: To discuss articles in this week’s MMWR on TB prevention and control. Brief remarks followed by Q/A.
WHEN: Thursday, March 21, 2002; 12 Noon – 12:30 PM ET
WHERE: At your desk, by toll-free conference line: Dial 866-254-5942
Teleconference name: CDC
A full transcript of this teleconference will be available today following the teleconference on the CDC website at www.cdc.gov/media.

This teleconference will also be audio webcast. Listen LIVE online at www.cdc.gov/media.

Synopsis for March 22, 2002

Tuberculosis Outbreak on an American Indian Reservation — Montana, 2000–2001

This report details an outbreak of TB on an Indian reservation in Montana, where TB spread from one patient to four additional individuals.

PRESS CONTACT:
Office of Communications

CDC, National Center for HIV, STD and TB Prevention
(404) 639–8895

 

Researchers found that routine contact investigations during this outbreak identified only one of the secondary TB cases. An analysis of the contact investigation procedures revealed that regular alcohol-drinking partners, who were at increased risk for TB because of prolonged exposure to the index case, had been overlooked when the initial investigation focused primarily on family members. As national TB rates continue to decline, public health officials and health care providers will need continuing education to remain proficient in the diagnosis and treatment of people with TB. At Fort Belknap, where only one case of TB had been reported in the prior eight years, health care providers collaborated early in the investigation with federal and state public health officials and pulmonary specialists to bolster TB control skills.

 

Progress Toward Tuberculosis Control — India, 2001

Following implementation of the Revised National TB Control Program in 1998, India has made remarkable progress in combating one of the world's largest TB epidemics.

PRESS CONTACT:
Office of Communications

CDC, National Center for HIV, STD and TB Prevention
(404) 639–8895
 

In this report, the government of India and CDC review progress made towards controlling TB and outline remaining barriers in a country that now experiences 2 million TB cases annually – nearly one-fourth of the world's new TB cases. Since implementation, death rates among TB patients in areas served by the Revised National TB Control Program have dropped to 4%, compared to previous estimates of up to 29%. Researchers attribute this success to expanded use of directly observed therapy, a secure supply of TB drugs, improved diagnostic tools, and the use of disease surveillance system which allows officials to document trends in the number of TB cases and treatment outcomes. However, several key challenges remain, most notably the level of poverty.

 

Progress Towards Elimination of Haemophilus influenzae Type b Invasive Disease Among Infants and Children — United States, 1998–2000

Before effective vaccines became available in the U.S., Hib was the leading cause of bacterial meningitis and other serious diseases among children <5 years of age.

PRESS CONTACT:
Chima Ohuabunwo, MBBS

CDC, National Immunization Program
(404) 639–8255
 

Compared with incidence from the pre-vaccine era, by 1996, due to the widespread use of Hib conjugate vaccines, the incidence of Hib invasive disease among children <5 years of age declined by >99%. During 1998-2000, the national incidence of Hib invasive disease among children <5 years of age remained low. However, illness and death associated with the Hib bacteria occurred mostly among young infants who have not completed the 2-dose (given at 2 and 4 months of age) or 3-dose (given at 2, 4 and 6 months of age) primary series of Hib vaccination, and unvaccinated or under-vaccinated older children. Cases that occurred in children who had been old enough to complete the primary Hib vaccination series might have been preventable.

 


Media Home | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed March 21, 2002
URL:

United States Department of Health and Human Services
Centers for Disease Control and Prevention
Office of Communication
Division of Media Relations